Quantitative TP53 circulating tumor DNA predicts tumor response and survival outcomes in esophageal squamous cell carcinoma
World Journal of Gastrointestinal Oncology · 15.08.2026 · 18 (8)
DOI: 10.4251/wjgo.120942 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastrointestinal Oncology, online erschienen am 15.08.2026. Verfasst von Ren-Tong Gu und 5 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Reliable biomarkers for esophageal squamous cell carcinoma (ESCC) are critically needed. While circulating tumor DNA (ctDNA) shows promise, its utility in ESCC requires further validation. AIM To evaluate ctDNA as a dynamic biomarker for real-time tumor burden assessment and prognostic stratification in ESCC. METHODS Matched plasma, leukocyte, and tumor tissues from 63 ESCC patients were analyzed. We employed a tumor-informed, TP53 -specific ctDNA strategy, focusing on quantitative TP53 assessment to correlate postoperative ctDNA with clinical outcomes. RESULTS TP53 ranked as the gene most commonly found to be mutated. Preoperative TP53 ctDNA levels correlated with advanced T, N, and tumor-node-metastasis stages. Detection of TP53 ctDNA after surgery was associated with markedly poorer disease-free and overall survival. In neoadjuvant chemotherapy patients, post-treatment ctDNA status perfectly associated with pathological response. Multivariate analysis confirmed high preoperative TP53 ctDNA as an independent risk factor for recurrence. A tumor-agnostic analysis showed no prognostic value. CONCLUSION Quantitative TP53 ctDNA is a promising biomarker for real-time tumor response assessment and prognostic stratification in ESCC.
Zitieren
APA
Gu, R., Liu, T., Piao, Z., Jin, H., Wang, X., & Li, X. (2026). Quantitative TP53 circulating tumor DNA predicts tumor response and survival outcomes in esophageal squamous cell carcinoma. World Journal of Gastrointestinal Oncology, 18(8). https://doi.org/10.4251/wjgo.120942
Vancouver
Gu R, Liu T, Piao Z, Jin H, Wang X, Li X. Quantitative TP53 circulating tumor DNA predicts tumor response and survival outcomes in esophageal squamous cell carcinoma. World Journal of Gastrointestinal Oncology. 2026;18(8). doi:10.4251/wjgo.120942
BibTeX
@article{Gu2026,
author = {Gu, Ren-Tong and Liu, Tao and Piao, Zhi-Sheng and Jin, Hai and Wang, Xiao-Wei and Li, Xin},
title = {Quantitative TP53 circulating tumor DNA predicts tumor response and survival outcomes in esophageal squamous cell carcinoma},
journal = {World Journal of Gastrointestinal Oncology},
year = {2026},
volume = {18},
number = {8},
doi = {10.4251/wjgo.120942}
}
EUVIMED